R-Zero Stock
Operations, Productivity And CommunicationLooking to sell R-Zero stock or options?
R-Zero specializes in biosafety technology products aimed at minimizing viral health threats. The company's innovative approach utilizes a mobile UV-C unit for disinfecting common areas, featuring user-friendly operation to efficiently sanitize large spaces. This enables cleaning teams to effectively curb the transmission of infectious diseases.
Investors Include:
Caisse de dépôt et placement du Québec, SOSV, WiL (World Innovation Lab), BMO Financial Group, Upfront Ventures, Civilization Ventures, Mayo Clinic, John Doerr, Qualcomm Ventures, HAX, Leadout Capital, United Capital of Silicon Valley, Impact Assets, Mayo Clinic Ventures, DBL Partners, Bedrock.